AI tools for breast cancer detection fall short of radiologists' expectations
About half of 215 surveyed members of the Society of Breast Imaging already use FDA-approved AI tools for breast cancer detection, but the results fall short of expectations. Only 35 percent report lower recall rates, while 59 percent had expected them. The gap between promise and reality runs…
No discussion yet. Be the first to share your thoughts!